Published in Epigenetics on September 06, 2016
Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology. Int J Mol Sci (2016) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59
limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res (2015) 14.81
WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res (2005) 12.88
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res (2013) 6.17
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol (2006) 4.35
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood (2009) 4.00
The epigenetic regulation of mammalian telomeres. Nat Rev Genet (2007) 3.82
Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med (1995) 3.74
A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer (1971) 3.71
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol (2005) 2.97
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol (2008) 2.94
CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A (2000) 1.86
Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction. Dev Cell (2005) 1.84
The Yin and Yang of YY1 in the nervous system. J Neurochem (2008) 1.68
The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev (1997) 1.49
Epigenetic regulation of telomeres in human cancer. Oncogene (2008) 1.33
Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature (2015) 1.32
Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem (2013) 1.24
Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol (2014) 1.17
A novel significance score for gene selection and ranking. Bioinformatics (2012) 1.14
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst (2005) 1.12
Functional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2A. J Biol Chem (1996) 1.11
A sympathetic neuron autonomous role for Egr3-mediated gene regulation in dendrite morphogenesis and target tissue innervation. J Neurosci (2013) 1.08
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis. J Immunol (2013) 1.07
Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health (2006) 1.07
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat Genet (2015) 1.05
Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer (1976) 1.02
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers. Genome Biol (2012) 1.02
CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res (2013) 1.00
A balance between the anti-apoptotic activity of Slug and the apoptotic activity of msx1 is required for the proper development of the neural crest. Dev Biol (2004) 1.00
Two closely linked Drosophila POU domain genes are expressed in neuroblasts and sensory elements. Proc Natl Acad Sci U S A (1991) 0.99
Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer (2011) 0.98
Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest. Lancet Oncol (2012) 0.94
Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons. J Neurochem (2007) 0.94
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol (2003) 0.91
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights. Epigenomics (2015) 0.90
Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation. Cell Growth Differ (1999) 0.86
PAG-3, a Zn-finger transcription factor, determines neuroblast fate in C. elegans. Development (2002) 0.86
Endosomal acidification by Na+/H+ exchanger NHE5 regulates TrkA cell-surface targeting and NGF-induced PI3K signaling. Mol Biol Cell (2013) 0.86
Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres. J Pediatr Surg (2009) 0.85
DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing. Sci Data (2016) 0.82
Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma. PLoS One (2014) 0.81
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma. Oncotarget (2016) 0.79
Distribution of constitutively expressed MEF-2A in adult rat and human nervous systems. Synapse (2006) 0.78
Loss of function genetic screens reveal MTGR1 as an intracellular repressor of beta1 integrin-dependent neurite outgrowth. J Neurosci Methods (2008) 0.78
Telomere maintenance is pivotal for high-risk neuroblastoma. Cell Cycle (2015) 0.77